Clinical and Socioeconomic Burden of Respiratory Syncytial Virus in Iceland.
Ymir OskarssonAsgeir HaraldssonBryndis Hogna I OddsdottirTinna Laufey AsgeirsdottirValtýr Stefánsson ThorsPublished in: The Pediatric infectious disease journal (2022)
The clinical and socioeconomic disease burden of RSV in Iceland is substantial despite slightly lower hospital admission rates than other high-income countries. The prevention of RSV in young children, either through maternal or infant vaccination, has the potential to decrease both clinical and financial impact of the annual epidemics.